「胃・食道神経内分泌癌における治療標的分子発現の検討」の関連論文
-
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma
-
Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study
-
Expression of programmed cell death ligand-1 by immune cells in the microenvironment is a favorable prognostic factor for primary diffuse large B-cell lymphoma of the central nervous system
-
Role of PD-L1 expression during the progression of submucosal gastric cancer
-
食道扁平上皮癌におけるネクロトーシス関連分子の発現と腫瘍浸潤リンパ球に関する検討
-
Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma : A Reappraisal of 23 Japanese Patients Based on EBV Association and PD-L1 Expression in Tumor Cells
-
免疫組織化学検査を用いて子宮体癌の予後因子を再検討する
-
膵癌における腫瘍浸潤リンパ球と患者の生存に関連した三次リンパ組織の統合分析
-
Analysis of radiotherapy-induced alterations of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma
-
癌幹細胞マーカーが、食道扁平上皮癌における術前化学療法の抵抗性を予測する
-
シングルセルトランスクリプトーム解析を用いた食道扁平上皮癌内の腫瘍浸潤Bリンパ球における化学療法後の機能変化の解明
-
口腔扁平上皮癌における腫瘍浸潤T細胞の免疫プロファイル解析
-
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors
-
ニボルマブによる治療を行った転移性腎細胞癌患者における血清中可溶性PD-L1の予後予測効果
-
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
-
The Prognostic Significance of Peritumoral Lymphocytes’ Band-like Structure in Type II Endometrial Cancer
-
Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma
-
非小細胞肺癌におけるB7-1およびPD-1/PD-L1免疫チェックポイント分子の発現と転移巣での変化
-
肺腺癌におけるOvarian cancer immuno-reactive antigen domain containing 2 (OCIAD2) 発現の臨床病理学的意義および機能解析
-
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer
-
癌患者ゲノミクスデータ解析を基盤とした乳癌幹細胞性維持機構の解明
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma
-
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
-
術前化学療法を施行した食道扁平上皮癌におけるGlucocorticoid(GC)-Glucocorticoid receptor(GR)伝達経路関連因子の臨床病理学的,免疫組織学的検討
-
PD-L1に対するsiRNAを封入したHVJ-Eはマウスグリオーマにおいて免疫抑制性の環境を改善し抗腫瘍効果を惹起する
-
ホルモン受容体陽性・HER2陽性乳癌の腫瘍内不均質性に関する検討
-
Low level of stromal lectin-like oxidized LDL receptor 1 and CD8+ cytotoxic T lymphocytes indicate poor prognosis of colorectal cancer
-
前立腺生検組織におけるDSGb5糖鎖発現の臨床的意義について
-
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis
-
A multicenter, open‑label, single‑arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
-
混合型神経内分泌腫瘍における腫瘍組織微小環境の病理学的検討
-
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
-
GATA6とCK5の免疫組織化学的発現表現型が術前化学療法後切除膵癌の予後を層別化する
-
AFP産生胃癌の治療標的探索と腫瘍免疫回避機構
-
婦人科悪性腫瘍担癌患者におけるインターロイキン17産生性T細胞の変動と抗腫瘍薬がPD-L1を含む免疫関連因子に与える影響、及びPD-L1とインターロイキン17産生誘導因子との関連性についての検討
-
“その他の医原性免疫不全関連リンパ増殖性疾患”の臨床的特徴及び遺伝子変異解析についての研究
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
-
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma
-
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
-
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
-
Prognostic role of the innate immune signature CD163 and
-
Epstein-Barr Virus関連腫瘍におけるウイルス遺伝子発現と免疫回避・発癌機構の解明
-
転移・浸潤に関わるタンパク質Rho, ROCKの発現と、同時化学放射線療法後の子宮頸癌の予後との関係について
-
Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
Clinical significance of serglycin expression in human breast cancer patients
-
Prognostic role of the innate immune signature CD163 and
-
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy